2004•European Journal of PharmacologyRequires access

Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists

Qing Dallas-Yang, Xiaolan Shen, Mathias Z. Strowski, Edward J. Brady, Richard Saperstein, Raymond E. Gibson, Deborah Szalkowski, Sajjad A. Qureshi, Mari R. Candelore, Judith E. Fenyk-Melody, Emma R. Parmee, Bei B. Zhang, Guoqiang Jiang

Open publisher page 40 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 40 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Glucagon, Glucagon receptor, Internal medicine, Endocrinology, Glucagon-like peptide 1 receptor, Receptor, In vivo, Chemistry